Form 4: Quest Diagnostics Executive Sells Shares to Cover Tax Obligations

Michael J. Deppe, SVP, Corp. Controller & CAO of Quest Diagnostics, disposed of shares to cover tax withholding obligations from vesting restricted stock units.

Summary

• On February 26, 2025, Michael J. Deppe, SVP, Corp. Controller & CAO of Quest Diagnostics, disposed of 88 shares of common stock at a price of $171.75.
• The transaction was to cover tax withholding obligations arising from the vesting of restricted stock units.
• Following the transaction, Deppe directly owns 35,212 shares of Quest Diagnostics common stock.
• Deppe also indirectly owns 694 shares through the company's 401(k) plan.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to an executive's stock transactions. It doesn't inherently convey positive or negative sentiment about the company's performance or prospects.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it involves a small number of shares being sold by an executive to cover tax obligations.

Key Dates